Investigator Site 53 is a clinical research site located in Buffalo, New York, United States 14202.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Investigator Site 53 has participated in 1 clinical trials.
Therapeutic areas: Generalized Myasthenia Gravis.
Sponsors: argenx.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Investigator Site 53 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Investigator Site 53 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.
Investigator Site 53 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.